Tissue Plasminogen Activator Use: Evaluation and Initial Management of Ischemic Stroke from an Iowa Hospital Perspective-Reference-Cited by-同舟云学术

Tissue Plasminogen Activator Use: Evaluation and Initial Management of Ischemic Stroke from an Iowa Hospital Perspective

Published:2005-05 Issue:3 Volume:14 Page:127-135
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Albright Karen C.,Schott Todd C.,Jafari Neda,Wohlford-Wessels Mary Pat,Finnerty Edward P.,Jacoby Michael R.K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Rehabilitation,Surgery

Reference62 articles.

1. American Heart Association. Disease and stroke statistics–2004 update. Available from: UR:http://www.americanheart.org/presenter.jhtml?identifier=1200026. Accessed August 4, 2004.

2. Tissue plasminogen activator for acute ischemic stroke;N Engl J Med,1995

3. Effects of tissue plasminogen activator for acute ischemic stroke at one year;Kwiatkowski;N Engl J Med,1999

4. Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set;Hacke;Stroke,1998

5. Medicine;Marler;Science,2003

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care;Implementation Science;2015-12

2. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA);Journal of Clinical Pharmacy and Therapeutics;2012-06-19

3. Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting;Stroke;2012-05